Financial News
Pfizer stock jumps, Moderna, Merck tumble
November 05, 2021 at 13:28 PM EDT
Pfizer's stock soars after it delivers groundbreaking results for its COVID-19 oral antiviral candidate, PAXLOVID.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
